Study of Trans Sodium Crocetinate in Patients With Interstitial Lung Disease
Clinical trial NCT05079126 · TERMINATED
Trial details
- NCT number
- NCT05079126
- Sponsor
- Diffusion Pharmaceuticals Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-02
- Primary completion
- 2022-05-25
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.